Historical Analysis of the Risk of Hepatitis E and Its Complications in Pregnant Women in Nepal, 1996–1998

Author:

Scott Robert McNair1,Kmush Brittany L.2,Norkye Kundu13,Hada Meera3,Shrestha Mrigendra Prasad1,Vaughn David W.45,Myint Khin Saw Aye4,Endy Timothy P.4,Shrestha Sanjaya K.1,Innis Bruce L.67

Affiliation:

1. 1Walter Reed/AFRIMS Research Unit—Nepal, Kathmandu, Nepal;

2. 2Department of Public Health, Food Studies, and Nutrition, Syracuse University, Syracuse, New York;

3. 3Patan Hospital, Kathmandu, Nepal;

4. 4Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand;

5. 5Integrated Clinical Vaccine Development, Bill & Melinda Gates Foundation, Seattle, Washington;

6. 6Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, Maryland;

7. 7Global Vaccine Development, GlaxoSmithKline Biologicals, King of Prussia, Pennsylvania

Abstract

ABSTRACT. Hepatitis E (HE) during pregnancy can be fatal; there are no prospective risk estimates for HE and its complications during pregnancy. We followed 2,404 pregnant women for HE and pregnancy outcomes from 1996 to 1998. Subjects from Nepal were enrolled at an antenatal clinic with pregnancy of ≤ 24 weeks. Most women (65.1%) were anti-HE virus negative. There were 16 cases of HE (6.7 per 1,000); three mothers died (18.8%) having had intrauterine fetal death (IUFD). Thirteen mothers survived: five preterm and seven full-term deliveries, one IUFD. HE among seronegative women was the sole cause of maternal death and increased the risk of IUFD (relative risk [RR]: 10.6; 95% confidence interval [CI]: 4.29–26.3) and preterm delivery (RR: 17.1, 95% CI 7.56–38.5). HE vaccination of females in at-risk regions before or as they attain reproductive age would reduce their risk for preterm delivery, IUFD, and maternal death.

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Hepatitis E vaccine—Illuminating the barriers to use;PLOS Neglected Tropical Diseases;2023-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3